Biotech was starting to show signs of recovery after years of investor pullback—until new tariffs and economic uncertainty ...

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

Biotech entrepreneur Sam Waksal has been accused of "reckless conduct," including using a veterinary medicine on a severely ...

Trump administration cuts across federal health agencies have sent shivers through a biotech industry already struggling ...

Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the impact of mass layoffs at the FDA, impact on ...

Third Harmonic Bio is going to shut down, should shareholders accept a plan by directors to liquidate the San Francisco ...

There are four emerging powerhouses in China biotech: Henlius, BeiGene, Innovent and ZaiLab. All were founded in the 2010s, ...

With a "terrible" job market, empty labs, and mounting competition from China, the lifeblood of Kendall Square is under ...

The biotech mergers and acquisitions market faces significant headwinds in the first half of 2025. These challenges include frozen capital ...

Beth Marsh will lead commercialization for Neurotech, which gained FDA approval for its eye disease therapy. Neurotech in May ...

Political pressure and persistently high interest rates have some wondering if the industry’s model is broken.

Find out how you can mitigate risks when expanding your biotech business internationally in the current tariff and trade ...